Allogeneic corneal endothelial cell therapy (Aurion Biotech)

N/A

Report date: 2023/09/22 13:31:59

Base Information

Drug NameAllogeneic corneal endothelial cell therapy (Aurion Biotech)
Drug Alias NameVyznova
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsKeratitis
Global Approved IndicationsKeratitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2023/03/23
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAurion Biotech
China Registration ClassN/A

Develop Information

Active CompaniesAurion Biotech
Inactive CompaniesN/A
Active IndicationsKeratitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A